Cartesian Therapeutics Stock Technical Analysis
| RNAC Stock | 6.47 0.03 0.46% |
As of the 11th of February 2026, Cartesian Therapeutics shows the Mean Deviation of 3.54, standard deviation of 4.87, and Risk Adjusted Performance of (0.01). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cartesian Therapeutics, as well as the relationship between them.
Cartesian Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cartesian, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CartesianCartesian | Build AI portfolio with Cartesian Stock |
Cartesian Therapeutics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 35.57 | Strong Buy | 8 | Odds |
Most Cartesian analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cartesian stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cartesian Therapeutics, talking to its executives and customers, or listening to Cartesian conference calls.
Will Biotechnology sector continue expanding? Could Cartesian diversify its offerings? Factors like these will boost the valuation of Cartesian Therapeutics. Anticipated expansion of Cartesian directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cartesian Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.07) | Earnings Share (1.33) | Revenue Per Share | Quarterly Revenue Growth 0.168 | Return On Assets |
The market value of Cartesian Therapeutics is measured differently than its book value, which is the value of Cartesian that is recorded on the company's balance sheet. Investors also form their own opinion of Cartesian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cartesian Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Cartesian Therapeutics' market value can be influenced by many factors that don't directly affect Cartesian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cartesian Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cartesian Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cartesian Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cartesian Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cartesian Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cartesian Therapeutics.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Cartesian Therapeutics on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Cartesian Therapeutics or generate 0.0% return on investment in Cartesian Therapeutics over 90 days. Cartesian Therapeutics is related to or competes with Eupraxia Pharmaceuticals, Inventiva, Nautilus Biotechnology, Orchestra BioMed, Mediwound, Aardvark Therapeutics, and Fennec Pharmaceuticals. Cartesian Therapeutics is entity of United States More
Cartesian Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cartesian Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cartesian Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 7.26 |
Cartesian Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cartesian Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cartesian Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cartesian Therapeutics historical prices to predict the future Cartesian Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.25) |
Cartesian Therapeutics February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 3.54 | |||
| Coefficient Of Variation | (3,433) | |||
| Standard Deviation | 4.87 | |||
| Variance | 23.69 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 7.26 | |||
| Skewness | 0.4538 | |||
| Kurtosis | 1.98 |
Cartesian Therapeutics Backtested Returns
Cartesian Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0138, which signifies that the company had a -0.0138 % return per unit of risk over the last 3 months. Cartesian Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cartesian Therapeutics' Mean Deviation of 3.54, standard deviation of 4.87, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.62, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cartesian Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cartesian Therapeutics is expected to be smaller as well. At this point, Cartesian Therapeutics has a negative expected return of -0.0679%. Please make sure to confirm Cartesian Therapeutics' skewness, as well as the relationship between the daily balance of power and day typical price , to decide if Cartesian Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.18 |
Very weak predictability
Cartesian Therapeutics has very weak predictability. Overlapping area represents the amount of predictability between Cartesian Therapeutics time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cartesian Therapeutics price movement. The serial correlation of 0.18 indicates that over 18.0% of current Cartesian Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.24 |
Cartesian Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cartesian Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Cartesian Therapeutics across different markets.
About Cartesian Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cartesian Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cartesian Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cartesian Therapeutics price pattern first instead of the macroeconomic environment surrounding Cartesian Therapeutics. By analyzing Cartesian Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cartesian Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cartesian Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 2.67 | 0.54 | 0.62 | 0.59 | Revenue Per Share | 5.03 | 1.5 | 1.73 | 1.64 |
Cartesian Therapeutics February 11, 2026 Technical Indicators
Most technical analysis of Cartesian help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cartesian from various momentum indicators to cycle indicators. When you analyze Cartesian charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 3.54 | |||
| Coefficient Of Variation | (3,433) | |||
| Standard Deviation | 4.87 | |||
| Variance | 23.69 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 7.26 | |||
| Skewness | 0.4538 | |||
| Kurtosis | 1.98 |
Cartesian Therapeutics February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cartesian stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2,012 | ||
| Daily Balance Of Power | (0.14) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 6.49 | ||
| Day Typical Price | 6.49 | ||
| Price Action Indicator | (0.04) |
Complementary Tools for Cartesian Stock analysis
When running Cartesian Therapeutics' price analysis, check to measure Cartesian Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cartesian Therapeutics is operating at the current time. Most of Cartesian Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cartesian Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cartesian Therapeutics' price. Additionally, you may evaluate how the addition of Cartesian Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |